Source: Pharmaceuticals. Unidades: IQ, IFSC
Subjects: MELANOMA, NEOPLASIAS, PLANEJAMENTO DE FÁRMACOS
ABNT
DIAS, Júlia Scaff Moreira et al. Ruthenium(II) complex with 1-hyhdroxy-9,10-anthraquinone inhibits cell cycle progression at G0/G1 and induces apoptosis in melanoma cells. Pharmaceuticals, v. 18, n. Ja 2025, p. 63-1-63-26 + supplementary materials, 2025Tradução . . Disponível em: https://doi.org/10.3390/ph18010063. Acesso em: 21 jan. 2025.APA
Dias, J. S. M., Silva, G. Á. F., Viana, R. B., Araujo Neto, J. H., Ellena, J., Corrêa, R. de S., et al. (2025). Ruthenium(II) complex with 1-hyhdroxy-9,10-anthraquinone inhibits cell cycle progression at G0/G1 and induces apoptosis in melanoma cells. Pharmaceuticals, 18( Ja 2025), 63-1-63-26 + supplementary materials. doi:10.3390/ph18010063NLM
Dias JSM, Silva GÁF, Viana RB, Araujo Neto JH, Ellena J, Corrêa R de S, Barbosa MIF, Ionta M, Doriguetto AC. Ruthenium(II) complex with 1-hyhdroxy-9,10-anthraquinone inhibits cell cycle progression at G0/G1 and induces apoptosis in melanoma cells [Internet]. Pharmaceuticals. 2025 ; 18( Ja 2025): 63-1-63-26 + supplementary materials.[citado 2025 jan. 21 ] Available from: https://doi.org/10.3390/ph18010063Vancouver
Dias JSM, Silva GÁF, Viana RB, Araujo Neto JH, Ellena J, Corrêa R de S, Barbosa MIF, Ionta M, Doriguetto AC. Ruthenium(II) complex with 1-hyhdroxy-9,10-anthraquinone inhibits cell cycle progression at G0/G1 and induces apoptosis in melanoma cells [Internet]. Pharmaceuticals. 2025 ; 18( Ja 2025): 63-1-63-26 + supplementary materials.[citado 2025 jan. 21 ] Available from: https://doi.org/10.3390/ph18010063